Healthcare Sales & Marketing Network News: Trokendi XR

Searching News Database: Trokendi XR

HSMN NewsFeed - 6 Apr 2017
Supernus Receives Final FDA Approval for Trokendi XR(R) for Migraine Prophylaxis in Adults and Adolescents
Biopharmaceuticals FDA

HSMN NewsFeed - 7 Mar 2017
Supernus Announces Settlement with Zydus on Trokendi XR(R) Patent Litigation
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 13 Dec 2016
Supernus Wins Appeal Case on Oxtellar XR(R)
Biopharmaceuticals Neurology Litigation

HSMN NewsFeed - 8 Feb 2016
Supernus Prevails in Oxtellar XR(R) ANDA Litigation
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 25 Dec 2013
Supernus Announces Resignation of Board Member
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 19 Aug 2013
Supernus Announces Final FDA Approval and Upcoming Launch of Trokendi XR(TM)
Biopharmaceuticals Neurology FDA Product Launch

HSMN NewsFeed - 7 Aug 2013
Supernus Sues Watson for Infringement of Oxtellar XR(TM) Patents
Biopharmaceuticals Generics Neurology Litigation

HSMN NewsFeed - 22 Oct 2012
Supernus Receives FDA Approval for Oxtellar XR(TM) in Epilepsy
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 20 Jul 2012
Supernus Appoints Dr. Stefan Schwabe, MD, PhD as Exec. VP R&D and Chief Medical Officer
Biopharmaceuticals Personnel

Return to NewsFeed

FindReps - Find Great Medical Independent Sales Reps without recruiter fees.

FindReps - available on the Apple App Store for iPhone and iPad.